Target intelligence / Profile preview

Parasitic worm voltage-gated calcium channel

Molecular classification
Ion channel, Voltage-gated calcium channel (Ca_v channel), Transient receptor potential channel (TRPM) (certain flatworms)
01

Overview

Parasitic worm calcium channels, most notably *voltage-gated calcium channels* (Ca_v), are membrane protein complexes involved in mediating the influx of extracellular calcium ions in response to membrane depolarization. These channels are critical for *muscle contraction*, *motility*, and other physiological functions in adult parasitic worms such as schistosomes (causative agents of schistosomiasis)[5][4][3]. The pore-forming \u03b1_1 subunit is modulated by unique auxiliary subunits in schistosomes, and some flatworms possess novel channel subtypes like TRPM_{PZQ}, which is directly targeted and activated by praziquantel therapy, leading to sustained calcium entry and worm paralysis[3][4]. Drug resistance has emerged as a therapeutic issue due to genetic variants in the TRPM_{PZQ} binding pocket[3]. Other compounds, such as nifedipine (a general L-type Ca_v channel blocker), have demonstrated efficacy against worm calcium channels, supporting their utility as validated drug targets[2][5]. **Note:** The name "Parasitic worm calcium channels" is *not a canonical full name*\u2014it represents an entire class of channels rather than a specific molecular entity. For most drug targeting purposes, the more precise name would be "Schistosoma mansoni transient receptor potential melastatin ion channel (TRPM_{PZQ})" or "Schistosoma mansoni voltage-gated calcium channel," depending on target specificity[3][4][5][7]. The current entry is overly broad and should be refined for structured use. **Correction (is_incorrect flag):** The target name "Parasitic worm calcium channels" is overly generic and combines multiple related but distinct ion channel types, some of which are only partially characterized or may not be targeted directly by available drugs[3][4][5][7]. For accurate structured information, the target should be specified to the protein subtype most relevant to drug action\u2014for example, *TRPM_{PZQ}* for schistosome praziquantel sensitivity[3], or voltage-gated Ca_v channel in specific nematodes or flatworms[5][7][4].

Other names
Parasitic worm Ca(^{2+}) channelFlatworm voltage-gated calcium channelSchistosome Ca(^{2+}) channelVoltage-operated calcium channel (VOCC) (parasite-specific context)
02

Mechanism of action

*Praziquantel:* Activates TRPM_{PZQ} channels, causes sustained Ca^{2+} influx and muscular paralysis of the worm, leading to death[3][4][5]. *Nifedipine:* Blocks L-type Ca^{2+} channels, disrupting Ca^{2+} homeostasis and causing worm motility impairment and death[2][5]. *Emodepside:* Activates SLO-1 (BK-type Ca^{2+}-activated K^{+} channels) in nematodes, not directly on Ca^{2+} channels but functionally related[4][8].

03

Biological functions

Regulation of neuromuscular activityControl of parasite motilityHost cell invasionCalcium homeostasisSignal transduction
04

Disease associations

InfectionParasitic diseases (schistosomiasis, helminthiasis)
05

Safety considerations

Praziquantel is ineffective against immature (liver-stage) worms[4]Emerging resistance to praziquantel in field isolates due to TRPM_{PZQ} sequence variation[3]Off-target effects on host calcium channels (not common for praziquantel; more relevant for general calcium channel antagonists like nifedipine)[2][5]Limited drug options targeting this mechanism; only praziquantel widely used, resistance is a serious concern[4]
06

Interacting drugs

Praziquantel

2 more in the full profile.

07

Biomarkers

Specific sequence variants of TRPM_{PZQ} channels (associated with praziquantel sensitivity)[3]Expression levels of voltage-gated Ca^{2+} channel subunits in schistosomes (potential research marker)[4][5]

Beyond the preview

Go deeper on Parasitic worm voltage-gated calcium channel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasitic worm voltage-gated calcium channel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call